Delcath Systems (DCTH)
(Delayed Data from NSDQ)
$10.64 USD
+0.12 (1.14%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $10.87 +0.23 (2.16%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth B Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DCTH 10.64 +0.12(1.14%)
Will DCTH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DCTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DCTH
Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates
Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates
DCTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is the Options Market Predicting a Spike in Delcath Systems Stock?
Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should Know
Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year?
Other News for DCTH
Delcath Systems price target raised by $1 at Clear Street, here's why
Delcath Systems Inc (DCTH) Q2 2025 Earnings: EPS of $0. ...
Delcath Systems reports Q2 EPS 7c, consensus 3c
Delcath Systems Reports Second Quarter 2025 Results and Business Highlights | DCTH Stock News
Delcath Systems GAAP EPS of $0.07 beats by $0.05, revenue of $24.2M beats by $1.18M